Diabetes educatie en zelfmanagement ter verbetering van empowerment bij diabetes type 2 patiënten

DESTINE trial – Diabetes Education & Self-management To INcrease Empowerment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28753

Enrollment

200

Registered

2014-07-16

Start date

2014-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People diagnosed with type 2 diabetes mellitus (T2DM

Interventions

The intervention in case of PRISMA training will additionally consist of interdisciplinary group training that will inform him/her of the possibilities of increase their self-management. PRISMA traini

Eligibility

Inclusion criteria

Inclusion criteria: 1. A diagnosis of T2DM mellitus, as 1. registered in the primary care system under the diagnosis T90.2, and where the GP is defined as the main care giver; 2. And aged ≥18 years.

Exclusion criteria

Exclusion criteria: 1. Mental retardation or psychiatric treatment for schizophrenia, organic mental disorder or bipolar disorder currently or in the past. 2. Insufficient knowledge of the Dutch language to understand the requirements of the study and/ or the questions posed in the questionnaires.

Design outcomes

Primary

Measure	Time frame
Study the effect of offering the PRISMA training to a T2DM patient on the use of the web portal and its educational content.	—

Secondary

Measure	Time frame
a. Study the effect of the use of the web portal and its educational content by a T2DM patient on quality parameters, as tested by: - WHO-5 scale, representing Well Being; - PAM, representing the Degree of Self Reliance; - HowRwe, representing Quality of Received Care; - SDSCA, representing Diabetes Self-management Behavior; - MARS-5, representing Self-Reported Adherence to Medication Prescriptions; - PEPPI-5, representing Patients’ Experience of Efficacy; - Patient participation during the medical consultation (video’s). b. Study the effect of the use of the web portal and its educational content by a T2DM patient on: - Clinical parameters, as described in the NHG / NAD core set of diabetes parameters (appendix 2); - Amount of prescribed (used) medicine; - Medical care utilization (number of contacts with health care representatives); - Rates and time of refills.	—

Measure

Time frame

a. Study the effect of the use of the web portal and its educational content by a T2DM patient on quality parameters, as tested by: - WHO-5 scale, representing Well Being; - PAM, representing the Degree of Self Reliance; - HowRwe, representing Quality of Received Care; - SDSCA, representing Diabetes Self-management Behavior; - MARS-5, representing Self-Reported Adherence to Medication Prescriptions; - PEPPI-5, representing Patients’ Experience of Efficacy; - Patient participation during the medical consultation (video’s). b. Study the effect of the use of the web portal and its educational content by a T2DM patient on: - Clinical parameters, as described in the NHG / NAD core set of diabetes parameters (appendix 2); - Amount of prescribed (used) medicine; - Medical care utilization (number of contacts with health care representatives); - Rates and time of refills.

—

Contacts

Public ContactE. Pon, du

Lectoraat Disseminatie van Farmaceutische Innovaties Bolognalaan 101 Postbus 85182

esther.dupon@hu.nl088 481 2102

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)